With the registrations opening a month prior, the 2 days antimicrobial research conference, 2024 (ARC 2024) started off on a great note on August 22, 2024, until August 23, 2024, covering latest research, policies and outreach towards better antimicrobial resistance (AMR), a global and urgent threat to public health.
The 2 days conference was structured around expert talks covering novel antimicrobials which could reduce the AMR burden and offer some respite to the multidrug resistant (MDR) bacterial infections, as well as a panel discussions on surveillance of AMR, AMR mechanisms, and a large spread of posters covering latest AMR based research, community engagement, outreach, knowledge sharing resources etc. The day 2 saw great presentations covering bacteriophage therapy as an alternate to treating bacterial infections in the face of MDR pathogens, AMR diagnostics and upcoming and novel antimicrobials, low-cost indigenized kits and assays followed by a panel discussion on AMR policy and challenges that exist in India and ways to improve the existing policies.
With over 100 participants from across India and across the globe, the AMR conference served as a platform to share knowledge, joint dialogue with scientists, clinicians, administrators and public health and policy makers to better the existing tools and strategies for infection prevention and control, regulated antimicrobial prescriptions and consumption, AMR stewardship and role of active community engagement. A combination of top-down approach to prohibit over-the-counter uncontrolled sales of antimicrobials, better AMR policies, and bottoms-up approach to educate at grass-root levels, community level and at the hospitals to trainees and practicing physicians.
Link to the 2 days program module: https://www.ncbs.res.in/events/tigs
Lead by Dr. Arati Ramesh,
Principal Scientist,
TIGS
and
Dr. Anjana Badrinarayan,
Faculty, NCBS